MedTrace Logo

Safety and Efficacy Study

NCT02670863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 239

Last updated 2021-10-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the experimental formula supplemented with a prebiotic vs the control formula.

Conditions

  • Infant Term Birth

Interventions

OTHER

Experimental Infant Formula

Standard bovine milk-based term infant formula supplemented with a prebiotic, fed ad libitum

OTHER

Standard Infant Formula

Standard bovine milk-based term infant formula, fed ad libitum

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Elvira M Estorninos, MD · Asian Hospital and Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Days
Max Age
26 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-21
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02670863 on ClinicalTrials.gov